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WHAT THIS PAPER ADDS
 Cervical radiation therapy is a risk factor for the development of carotid artery stenosis and subsequent cerebrovascular events.
Differences between atherosclerotic-induced stenosis and radiation-induced stenosis have mainly been based on descriptions of
clinical patient factors and angiographic lesion characteristics, but to our best knowledge histological assessment of radiation-
induced plaques has never been performed in human subjects.
 Phenotype of carotid plaque has proven to be clinically relevant, due to close associations with presenting primary cerebrovascular
events and as an independent predictor of future cardiovascular events and restenosis. Current study provides results of prognostic
value for previously radiated patients.a r t i c l e i n f o
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Objective: To identify plaque characteristics of carotid artery radiation-induced stenosis.
Materials and methods: Nineteen carotid plaques were obtained during carotid endarterectomy (CEA) in
17 consecutive patients with prior cervical radiation therapy (XRT) (median interval 10 years) and
compared with 95 matched control carotid plaques of patients without a history of XRT. The following
histopathological factors were assessed: calciﬁcation, collagen, macrophages, smooth muscle cells,
atheroma, microvessels and intraplaque haemorrhage. Association of individual histological parameters
with XRT plaque was analysed through a multivariable regression model.
Results: Less inﬁltration of macrophages (6/19 versus 60/95, adjusted p ¼ 0.003) and a smaller lipid core
size (Atheroma >10%: 10/19 versus 80/95, adjusted p ¼ 0.006) were independently associated with XRT
plaque, compared to non-XRT plaques.
Conclusions: Carotid stenotic lesions in patients with previous cervical radiation are less inﬂammatory
and more ﬁbrotic than carotid atherosclerotic lesions in non-radiated patients.
 2012 European Society for Vascular Surgery. Published by Elsevier Ltd. All rights reserved.Severe carotid stenosis after previous cervical radiation is
considered a high-risk condition for revascularisation.1 A causal
relationship of cervical radiation therapy (XRT) and development of
carotid stenosis has been shown in previous studies.2,3 Further-
more, in patients with carotid stenosis following prior XRT for headt, Dep. of Vascular Surgery,
lands. Tel.: þ31 88 7556965;
de Borst).
ciety for Vascular Surgery. Publisheand neckmalignancy, an increased stroke ratewas demonstrated as
compared to patients without a history of XRT.4
The underlying physiopathological mechanism of carotid
stenosis after cervical XRT resulting in higher stroke risk remains
unclear, although different pathways have been suggested.5,6
Differences between atherosclerotic-induced stenosis (AIS) and
carotid stenosis after XRT have mainly been based on description of
macroscopic morphologic lesion components and clinical patient
characteristics. Clinically, XRT patients are younger and have
a lower incidence of other risk factors (except hyperlipidaemia) ford by Elsevier Ltd. All rights reserved.
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XRT lesions have a higher degree of stenosis, are likely to be longer
and appear on non-typical atherosclerotic sites (more frequent in
the external and common carotid artery).7e9 In addition, lesions of
XRT patients frequently demonstrated a hypoechoic focus and less
often shadowing compared with plaques found in atherosclerotic
patients.8 These ﬁndings indicate that lesions in previously irradi-
ated patients might act as a different disease entity compared to
atherosclerotic-induced stenosis (AIS). However, differences in
histological plaque characteristics have not been reported to date.
Phenotype of carotid plaque has proven to be clinically relevant,
due to close associations with presenting primary cerebrovascular
events.10 In addition, the local atherosclerotic plaque composition
has been shown to be an independent predictor of both future
cardiovascular events and restenosis.10,11 Thus far, only animal
studies and high-resolution magnetic resonance imaging (MRI)
studies have attempted to identify characteristics in carotid plaques
after radiation. With help of our longstanding Athero-Express
biobank,12 we aimed to study carotid plaques microscopically, to
identify plaque phenotype of patients with prior cervical XRT.
Methods
Design
This cross-sectional study was designed on patients who have
been included in the Athero-Express biobank (2002e2009).
Athero-Express is an ongoing longitudinal prospective study that
includes patients undergoing CEA in the participating centres St.
Antonius Hospital Nieuwegein and University Medical Center
Utrecht.12 After CEA, the carotid plaque is collected and subjected to
histological examination. All patients were asked to participate and
provided written informed consent. Data of patients were collected
prospectively, except for speciﬁc radiation characteristics, which
were gathered retrospectively. Baseline characteristics included (1)
demographic data: gender, age (at time of surgery), preoperative
clinical presentation (asymptomatic, transient ischaemic attack
(TIA), stroke and ocular symptoms), time between last symptoms
and CEA, degree of ipsilateral stenosis (diagnosed by carotid colour
Doppler-assisted duplex ultrasound and in most cases conﬁrmed
by magnetic resonance angiography (MRA) or computed tomog-
raphy angiography (CTA)); and (2) risk factors for atherosclerotic
disease: (current) smoking, hypertension, hypercholesterolaemia,
diabetes mellitus (DM), coronary artery disease (CAD), peripheral
artery disease of the lower limbs, renal function (expressed in
glomerular ﬁltration rate, GFR (ml min1 1.73 m2) and body mass
index (BMI) (kg m2)). Hypertension and hypercholesterolaemia
were by deﬁnition restricted to those cases using blood pressure-
lowering drugs respectively statins. DM was deﬁned as use of
insulin or oral glucose inhibitors.
Patients
All previously radiated patients (XRT group) underwent
consecutively CEAwith histological plaque analysis according to the
Athero-Express protocol. All patients with previous cervical radia-
tion andCEAwere selectedout of theAthero-Expressdatabase. They
were matched to patients (out of the same database) without
a history of XRT (non-XRT group) for (1) gender, (2) age (at time of
surgery) and (3) clinical presentation. A control group of non-XRT
plaques (1:5 ratio) was selected per XRT plaque, based on previ-
ously recommended criteria for case control studies.13 In the total
study period, 1250 CEAs were performed for 85% symptomatic and
15% asymptomatic patients. Of those, 19 carotid plaques (1.5% of
total surgeries) from 17 consecutive patients (median age: 69 years(range56e92),15males)withprevious cervical XRTwere compared
to 95 matched controls (median age: 69 years (range 56e90), 76
males) without a history of cervical XRT. The same treatment
regimen was followed for radiated and non-radiated patients.
Plaque assessment and outcome
Conforming to a standardised protocol, the carotid plaque
obtained during CEA was divided into segments of 5 mm thickness
along the longitudinal axis.12 The segment with the greatest plaque
burden, the culprit lesion, was subjected to histological examina-
tion. Outcome of plaque characteristics was analysed microscopi-
cally by observers of the Athero-Express blinded for XRT status.
Histological outcome parameters were widely accepted measures
for atherosclerotic plaque stability and included: calciﬁcation,
collagen, macrophages, smooth muscle cells (SMCs), fat, micro-
vessels and intraplaque haemorrhage (IPH). Semi-quantitative
estimation of the plaque morphology was performed for calciﬁca-
tion (haematoxylin and eosin (H&E)), collagen (picro Sirius red
(PSR)), macrophages (CD 68) and SMC (alpha actin). Plaque char-
acteristics were scored as (1) no/minor staining or (2) moderate/
heavy staining. In addition, atheroma (PSR and H&E) was analysed
as the percentage of the plaque occupied by the lipid core (<10% or
>10%). Microvessels (CD 34) were determined by the average
number of CD 34-immunopositive microvessels of three hot spots
within every plaque. For multivariable analysis, amount of micro-
vessels was dichotomised as either below or above the median. IPH
(H&E and Elastin von Gieson stainings) was rated as being absent or
present.
Finally, overall plaque phenotype was established by overall
appearance. A plaque is considered more active and unstable when
it reveals a strong staining for macrophages, a large atheroma and
when it lacks collagen and SMCs.14 The more ﬁbrous stable lesion
typically lacks inﬂammatory cells and fat and reveals strong
staining for collagen and SMCs. The Athero-Express deﬁnes this as:
ﬁbrous plaque (<10% of the plaque is occupied by lipid with
abundant presence of collagen and smooth muscle cell (SMC)),
ﬁbro-atheromatous plaque 10e40% (between 10 and 40% is occu-
pied by fat) and atheromatous plaque (>40% of the plaque hides
atheroma with presence of macrophages).12
Statistical analysis
Statistical Package for the Social Sciences (SPSS) 17.0 was used
for all analyses (SPSS Inc., Chicago, IL, USA). For dichotomised
factors, we used crosstabs and Chi-square tests to calculate absolute
risks (%) and p-values. Continuous characteristics were analysed
with non-parametric ManneWhitney U test since parameters were
not normally distributed. P-values <0.05 were considered statisti-
cally signiﬁcant. The univariate analysis including baseline
parameters served as the basis for a multivariable logistic regres-
sion model to test if the histological parameters were indepen-
dently associated with XRT plaque. Baseline characteristics
showing association (P < 0.20) with XRT exposure in univariate
analysis were included in the (unconditional) multivariable model
to correct for confounders. Associations were calculated using
‘enter’ method and reported as adjusted odds ratios (ORs) with 95%
conﬁdent intervals (CIs) for all variables in the ﬁnal model.
Results
XRT patients
Median interval between XRT and carotid revascularisation was
10 years (range 1.8e24.0 years). The underlying malignant disease
Table 2
Demographic and clinical characteristics of the study population.a
Demographic characteristics XRT-plaque
(n ¼ 19)
Non-XRT
plaque
(n ¼ 95)
P-value
Age, years (median, range) 69 (56e92) 69 (56e90) 0.903
Sex 0.917
Male 15 (78.9) 76 (80.0)
Clinical presentation
Asymptomatic 1 (5.3) 5 (5.3) 0.929
Symptomatic 18 (94.7) 90 (94.7)
Stroke 4 (21.1) 20 (21.1)
TIA 11 (57.9) 60 (63.2)
Ocular 3 (15.8) 10 (10.5)
Time between event and
surgery, days (median, range)
35 (2e205) 66 (1e364) 0.099
Degree of ipsilateral stenosis 0.091
70e90% 15 (73.7) 50 (52.6)
90e99% 5 (26.3) 45 (47.4)
Risk factors
Current smoker 7 (38.9) 33 (37.5) 0.912
Hypertension 17 (89.6) 84 (88.4) 0.895
Hypercholesterolaemia
(statin use)
14 (82.4) 67 (71.3) 0.344
Diabetes mellitus 3 (15.8) 22 (23.2) 0.692
Coronary artery disease 3 (15.8) 19 (20.0) 0.671
Peripheral artery disease 4 (21.1) 26 (27.4) 0.568
GFR (median, range) 66 (46e110) 67 (17e124) 0.849
BMI (median, range) 24 (22e29) 27 (18e39) 0.001
Bold value indicates a signiﬁcance level of p < 0.05.
TIA, transient ischaemic accident; GFR, glomural ﬁltration rate in ml/min/1.73 m2;
BMI, body mass index calculated as weight in kilogrammes divided by height in
metres squared.
a Data are presented as No (%) unless otherwise indicated.
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carcinoma (n ¼ 4, 23.6%), cervical metastases of unknown primary
tumour (n ¼ 3, 17.6%), oral cavity tumours (n ¼ 2, 11.8%), neck
lymphomas (n ¼ 2, 11.8%), carcinoma of the nose (n ¼ 1, 5.9%) and
carcinoma of the jaw bone (n ¼ 1, 5.9%). The exact cervical levels
that had been radiated were not always exactly deﬁned but
included the affected carotid region in all cases. Median radiation
dose received was 355 Gy (range 30e7000). Patient characteristics
are summarised in Table 1.
Baseline characteristics
Comparisons of demographic characteristics and risk factors
between XRT group and non-XRT group are shown in Table 2.
Overall, 17 (94.4%) lesions of the XRTgroup and 90 (94.7%) lesions of
the non-XRT group were symptomatic (p ¼ 0.93). A tendency
towards a shorter interval between last event and surgery for XRT
group was identiﬁed compared to non-XRT group; 35 days (range:
2e205) versus 66 days (range 1e364, p ¼ 0.099). Also, all lower
percentage of previous radiated patients had a severe degree
(90e99%) of preoperative ipsilateral stenosis as compared to
control non-XRT patients (26.3% versus 47.4%, p ¼ 0.091). Consid-
ering risk factors for atherosclerosis, BMI differed signiﬁcantly
between both groups. A median BMI of 24 was seen in XRT group,
versus 27 in non-XRT group (p ¼ 0.001). Other risk factors did not
show any differences between the two groups.
Histological plaque composition
In univariate analysis, a signiﬁcant difference was identiﬁed for
inﬁltration of macrophages and atheroma >10%. Marked inﬁltra-
tion of macrophages (moderate or heavy) was less frequently
observed in XRT-plaques 31.6% (6/19) as compared with non-XRT
plaques 63.8% (60/95) (p ¼ 0.009). More ﬁbrous plaques were
identiﬁed in the XRT group; XRT plaques were associated with
a smaller lipid core size compared to non-XRT plaques. A total of
84.2% (80/95) of the control plaques contained more than 10%Table 1
Characteristics of previously radiated patients.
Age Gender Malignancy Lesion
side
Intervala
(years)
Received
doses (cGy)
96 F Glottis larynx ca R 13.1 7000
86 M Glottis larynx ca R 20.0 n.a
70 F Hypopharynx ca R 1.8 n.a
78 M Pharynx ca L 8.0 n.a
68 M Oropharynx ca L 4.2 30
72 M Larynx ca L 18.0 n.a
77 M Malignant lymphoma
tongue base
R 10.0 40
60 M Nasopharynx ca R 9.0 n.a
b b b L 11.0 n.a
64 M Non Hodgkin Lymfoma L 12.9 355
74 M Sqaumouscell ca nose L 3.5 70
66 M Tongue base ca, metastasis
lymfnode
R 24.0 n.a
85 M Squamous cell metastase
lymfnode
L 3.6 5000
73 F Squamous cell metastase
lymfnode
R 14.0 n.a
64 M Tongue base ca, squamous L 8.2 5000
75 M Tongue base ca R 6.0 n.a
b b b L 6.0 n.a
69 F Jaw bone ca R 15.0 n.a
73 M Larynx ca R 21.0 n.a
cGy, centi-Grey; F, female; M, male; ca, carcinoma; R, right; L, left; n.a, no data
available.
a Time between end of radiation therapy to carotid endartectomy.
b Same patient as 1 line above, bilateral stenosis.atheroma, compared to only 52.6% (10/19) in the XRT plaque
(p ¼ 0.002) (Table 3).
In multivariable logistic regression analysis, inﬁltration of
macrophages and atheroma >10% were independently associated
with XRT plaques after adjusting for time between event and
surgery, ipsilateral degree of stenosis and BMI (Adjusted OR 0.094
(95% CI 0.020e0.455) resp. 0.129 (95% CI 0.030e0.553) adjusted
p ¼ 0.003 resp. p ¼ 0.006). The ﬁgure represents the histologically
visualised result (Fig. 1). Other histological parameters, including
calciﬁcation, collagen, SMC, microvessels and IPH were not signif-
icantly associated with XRT status (Table 4).Discussion
In this study, we compared histological characteristics of carotid
plaques of patients with prior XRT with plaques from non-radiated
patients. A more ﬁbrous and less inﬂammatory plaque was
observed in XRT patients compared to plaques derived from non-
XRT patients.
Soon after the introduction of radiation therapy, around 1940
cardiovascular changes following radiation were recognised and
discussed in animal studies.15,16 An experimental study on the large
vessels of irradiated mice found progressive changes consisting of
intimal proliferation, fragmentation of the elastic lamina, over-
production of elastic tissue, necrosis, hyaline thickening and
production of collagen.15 Lindsey et al. irradiated localised
segments of the abdominal aorta in dogs.16 They observed arte-
riosclerotic changes consisting of selective disruption of the
internal elastic layer and the development of intimal thickening
without histological demonstrable injury to other layers of the
vessel wall. Although above described changes were all short to
mid-term effects (<17 months following radiation), response of
radiation may have latency up to 20 years before the onset of
Table 3
Histological outcome.a
Histological characteristics XRT plaque
(n ¼ 19)
Non-XRT
plaque
(n ¼ 95)
P-value
Calciﬁcation, moderate/heavy 8 (42.1) 58 (61.1) 0.127
Collagen, moderate/heavy 14 (73.7) 73 (86.8) 0.768
Macrophages, moderate/heavy 6 (31.6) 60 (63.8) 0.009
SMC, moderate/heavy 11 (57.9) 59 (62.1) 0.731
Atheroma >10% 10 (52.6) 80 (84.2) 0.002
Microvessels (median, range) 4.3 (0.3e25.0) 7.0 (1.3e40.3) 0.060
IPH present 5 (26.3) 31 (32.6) 0.589
Overall plaque phenotype
Fibrous 11 (57.9) 28 (29.5) 0.058
Fibro-atheromatous 3 (15.8) 27 (28.4)
Atheromatous 5 (26.3) 40 (42.1)
Bold values indicates a signiﬁcance level of p < 0.05.
SMC, smooth muscle cells; IPH, intraplaque haemorrhage.
a Data are presented as No (%) unless otherwise indicated.
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the irradiated artery; the interval being longer for larger arteries.17
Based on these early experimental ﬁndings and additional infor-
mation of non-invasive imaging techniques on humans, arterial
damage after radiation has been reported to be similar to non-
irradiated atherosclerotic lesions in more recent human stud-
ies.18e20 These studies suggested that radiation only accelerates the
normal process of atherosclerotic stenosis. This theory is ques-
tionable, considering our results in human plaques. Results showed
important differences between XRT plaques (at a median time
interval of 10 years after radiation) and non-XRT plaques in a very
comparable, mainly symptomatic (94.7%) patient population. AfterFigure 1. Carotid plaque histology of radiated and non-radiated patients. Histological analy
eosin staining showing macrophages (left) at the border of an atheroma (right). Bar ¼ 200 mm
the same plaque as A with heavy staining of macrophages. C and D, XRT plaque. C, Haem
Bar ¼ 200 mm. D, no macrophages are present in the macrophage staining (CD68 immunomatching, baseline characteristics ‘time interval between last event
and surgery’, ‘degree of ipsilateral stenosis’ and ‘BMI’ varied
between both groups. For BMI, no differences in plaque composi-
tion have been described in literature. Unexpected, degree of
preoperative stenosis was less severe in XRT group compared to
non-XRT group. Results were not signiﬁcant and should be inter-
preted with caution because of small groups. Time interval differ-
ences seem to be more relevant because histological studies have
shown that remodelling of the plaque after a symptomatic event
leads to more stable plaques over time. After stroke, the content of
macrophages decreases signiﬁcantly over a relatively short
time.21,22 However, despite ‘time between last event and CEA’ being
shorter in the XRT group compared with non-XRT patients (35
versus 66 days), we observed less macrophage inﬁltration and
a more ﬁbrous plaque in XRT group. Previous evidence emphasises
the strength of our observations in differences between athero-
sclerotic and radiated plaques. Due to our ongoing database, the
effect of timing of interventionwill become clear in the future since
CEA is now recommended to be performedwithin 2 weeks of a ﬁrst
clinical event.23
Since plaque characteristics are associated not only with clinical
presentation but also with outcome after CEA, our ﬁndings might
be of interest in the light of risk for further cardiovascular mani-
festations due to carotid stenosis-like TIA or stroke. Cerebrovas-
cular events are often a result of thrombus formation superimposed
on a so-called ‘vulnerable’ plaque.24 Although radiation therapy
increases the risk of symptomatic carotid stenosis, our observation
suggests that XRT plaques are less vulnerable, or more stable and
less active compared to non-radiated atherosclerotic lesions.10 The
explanation for this difference between reported clinical observa-
tions on increased stroke rate and our histology assessmentsis of carotid endarterectomy specimens. A and B, control plaque. A, Haematoxylin and
. B, immunohistochemical detection of macrophages (in brown; CD68 immunostain) in
atoxylin and eosin staining showing connective tissue and calciﬁcation in the plaque.
stain) of the same area as C.
Table 4
Histological outcome, adjusted Odds Ratios for the presence of plaque parameters in
patients with previous XRT as compared with controls.
Histological characteristics Adjusted odds ratioa
(95% CI)
Adjusted
P-valuea
Calciﬁcation 0.340 (0.087e1.328) 0.121
Collagen 0.612 (0.144e2.601) 0.506
Macrophage inﬁltration 0.094 (0.020e0.455) 0.003
SMC 0.595 (0.158e2.245) 0.443
Atheroma >10% 0.129 (0.030e0.553) 0.006
Microvessels > median (number
per hotspot)
0.480 (0.120e1.915) 0.299
IPH present 1.074 (0.286e4.039) 0.916
Bold values indicates a signiﬁcance level of p < 0.05.
CI, conﬁdence interval; SMC, smooth muscle cells; IPH, intraplaque haemorrhage.
a Adjusted for time between last event and surgery, ipsilateral preoperative
degree of stenose and body mass index (kg/m2).
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rupture of thrombus formation might lead to neurological symp-
toms, like progressive stenosis through intima-media thickening.25
Our ﬁndings, however, do ﬁt the clinical fact that radiated arteries
do create restenosis faster than non-radiated plaques, as we also
know that relatively stable and ﬁbrous plaques cause restenosis
more often than vulnerable plaques. More speciﬁcally, low
macrophage inﬁltration and small or absent lipid core is associated
with higher risk of restenosis (>50%) after CEA.11 Applying this
evidence for XRT plaques, patients could hypothetically be more
prone to develop restenosis after revascularisation following prior
XRT. Although current literature is conﬂicting, some data suggest
that previously radiated patients indeed have a higher risk for
restenosis than non-XRT patients after CEA.26 Evidence is more
clear for XRT patients treated with carotid angioplasty and stenting
(CAS), since rate of restenosis or occlusionwas calculated as 5.4 per
100 person-years (95% CI 4.3e6.6) compared to 2.8 per 100 person-
years (95% CI 1.9e4.0) after CEA (p ¼ 0.0025) in a recent literature
review.27 Possibly, high rates of restenosis after CAS can be partly
attributed to previous XRT status besides endovascular technique.
Limitations
In this study, we were able to perform analyses on 19 plaques of
17 patients. Small sample sizes are known for its lack of precision
and thus over- and underestimation of the relations under study.
Analysing a small number of patients is inevitable since incidence
of patients with previous XRTwho underwent CEA is low. However,
we believe this is an important group to report on. Furthermore,
despite the small sample size, we believe this data is valuable and
sufﬁcient tomeet with our study goal. Ideally, our results need to be
conﬁrmed in a prospective and a preferable larger cohort. Because
limited data on follow-up were available, we were not able to
analyse the possible consequences for clinical outcome and reste-
nosis. Also, we are not aware of the exact time course of the
development of radiation-induced lesions. Consequently, ﬁndings
on histological level only apply for plaques at a median time
interval after radiation of 10 years. For some cases, poor informa-
tion of radiation characteristics (site and dose) was reported.
However, this seems to be aminor problem since radiation-induced
stenosis was detected not only at the ipsilateral side, but also to
a same severe amount at the contralateral side of irradiation for
cervical malignancies by others.28,29 Findings can be explained by
the so-called ‘bystander effect’, whereas radiation of cells damages
not only the target cells, but also non-targeted bystander cells.30
Lastly, because of segments with the greatest plaque burden were
histological analysed, different segments of the carotid artery could
be analysed in the XRT group and in the non-XRT group. However,examination of a single culprit segment of the plaque is reasonably
representative for the plaque as a whole.22 Because physiopatho-
logical pathways of initial lesion stay the same, histologywill reﬂect
either atherosclerotic or radiation origin.
Conclusions
Lipid poor, non-inﬂammatory plaque is distinctive for carotid
plaques of previously irradiated and symptomatic patients,
compared to a non-irradiated atherosclerotic plaque. Consequences
for clinical outcome and restenosis after CEA need to be objectiﬁed
in larger cohorts with longer follow-up.
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